General
Showing 369–384 of 1897 results
-
Article: Co-inhibition of BRAF and MEK signalling delays progression in BRAF-mutant metastatic melanoma
€2.42 Add to cart -
Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
€2.42 Add to cart -
Article: Combined PD-1 and CTLA4 inhibition delays progression in advanced melanoma
€2.42 Add to cart -
Article: Comment on a previously published practice guidelines article
€2.42 Add to cart -
Article: Comparison of HIL interferences on three hemostasis analyzers and contribution of a preanalytical module for routine coagulation assays
€2.42 Add to cart -
Article: Comparison of point-of-care instruments I-STAT, ACTPlus and Hemochron Signature Plus for measurement of activated clotting time (ACT)
€2.42 Add to cart -
Article: Concerning a previously published Introduction
€2.42 Add to cart -
Article: Concerning a previously published practice guidelines article
€2.42 Add to cart -
Article: Concomitant JAK2 V617F positive essential thrombocytemia and BCR-ABL1 positive chronic myeloid leukaemia masked by imatinib therapy for a gastrointestinal stromal tumour
€2.42 Add to cart -
Article: Confirmed benefit of blinatumomab in difficult to treat patients with acute lymphoblastic leukemia
€2.42 Add to cart -
Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7
€2.42 Add to cart -
Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma
€2.42 Add to cart -
Article: Congratulations! Winner of the first CSL Behring Encouragement Grant
€2.42 Add to cart -
Article: Congress Calendar
€2.42 Add to cart -
Article: Congress Calendar
€2.42 Add to cart -
Article: Congress Calendar
€2.42 Add to cart
